PRECIGEN, INC. Inventory, Gross
PRECIGEN, INC. (PGEN) had Inventory, Gross of $20.25 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Inventory, Net › Inventory, Gross
us-gaap:InventoryGross · last filed 2026-08-04
- 2026-06-30: Inventory, Gross $20.25M.
- 2026-03-31: Inventory, Gross $14.72M.
- 2025-12-31: Inventory, Gross $9.58M.
- 2025-09-30: Inventory, Gross $3.06M.
| Period end | Inventory, Gross | Inventory, Gross as first filed |
|---|---|---|
| 2026-06-30 | $20.25M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $14.72M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $9.58M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $3.06M 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 | |
| 2022-12-31 | $287.00K 10-K · filed 2023-03-06 | |
| 2022-09-30 | $219.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $224.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $12.73M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $326.00K 10-K · filed 2023-03-06 | $13.26M 10-K · filed 2022-03-01 |
| 2021-09-30 | $9.94M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $11.41M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $10.64M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $11.36M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $10.35M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $12.73M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $14.64M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $16.10M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $17.30M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $18.19M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $19.90M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $20.57M 10-K · filed 2020-03-02 | $21.45M 10-K · filed 2019-03-01 |
| 2018-09-30 | $18.29M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $20.07M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $20.27M 10-Q/A · filed 2018-08-13 | |
| 2017-12-31 | $20.49M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $17.73M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $19.15M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $19.08M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $21.14M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $21.88M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $24.49M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $25.08M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $26.56M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $22.34M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $27.00M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $26.17M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $25.79M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $16.67M 10-Q · filed 2014-11-13 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |